{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T10:34:52Z","timestamp":1787654092682,"version":"build-2736575974"},"reference-count":50,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2018,6,1]],"date-time":"2018-06-01T00:00:00Z","timestamp":1527811200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"ELKE"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","semarthritisrheumatism.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seminars in Arthritis and Rheumatism"],"published-print":{"date-parts":[[2018,6]]},"DOI":"10.1016\/j.semarthrit.2017.10.015","type":"journal-article","created":{"date-parts":[[2017,10,23]],"date-time":"2017-10-23T16:09:28Z","timestamp":1508774968000},"page":"883-889","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":37,"title":["Carotid and femoral atherosclerosis in antiphospholipid syndrome: Equivalent risk with diabetes mellitus in a case\u2013control study"],"prefix":"10.1016","volume":"47","author":[{"given":"Evrydiki","family":"Kravvariti","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George","family":"Konstantonis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nikolas","family":"Tentolouris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Petros P.","family":"Sfikakis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria G.","family":"Tektonidou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.semarthrit.2017.10.015_bib1","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1016\/j.autrev.2012.11.007","article-title":"Thrombotic recurrences and bleeding events in APS vascular patients: a review from the literature and a comparison with the APS Piedmont Cohort","volume":"12","author":"Bazzan","year":"2013","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.semarthrit.2017.10.015_bib2","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1136\/annrheumdis-2013-204838","article-title":"Morbidity and mortality in the antiphospholipid syndrome during a 10-year period: a multicentre prospective study of 1000 patients","volume":"74","author":"Cervera","year":"2015","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.semarthrit.2017.10.015_bib3","doi-asserted-by":"crossref","DOI":"10.4049\/jimmunol.1600305","article-title":"Beta2 glycoprotein I recognition drives Th1 inflammation in atherosclerotic plaques of patients with primary antiphospholipid syndrome","volume":"198","author":"Benagiano","year":"2017","journal-title":"J Immunol"},{"key":"10.1016\/j.semarthrit.2017.10.015_bib4","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.clim.2012.12.002","article-title":"Dendritic cells: an important link between antiphospholipid antibodies, endothelial dysfunction, and atherosclerosis in autoimmune and non-autoimmune diseases","volume":"146","author":"Broder","year":"2013","journal-title":"Clin Immunol"},{"key":"10.1016\/j.semarthrit.2017.10.015_bib5","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1007\/s10875-014-0063-y","article-title":"Recombinant domain V of beta2-glycoprotein I inhibits the formation of atherogenic oxLDL\/beta2-glycoprotein I complexes","volume":"34","author":"Li","year":"2014","journal-title":"J Clin Immunol"},{"key":"10.1016\/j.semarthrit.2017.10.015_bib6","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1136\/annrheumdis-2013-204600","article-title":"Gene profiling reveals specific molecular pathways in the pathogenesis of atherosclerosis and cardiovascular disease in antiphospholipid syndrome, systemic lupus erythematosus and antiphospholipid syndrome with lupus","volume":"74","author":"Perez-Sanchez","year":"2015","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.semarthrit.2017.10.015_bib7","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1016\/j.autrev.2008.12.018","article-title":"The immunology of atherothrombosis in the antiphospholipid syndrome: antigen presentation and lipid intracellular accumulation","volume":"8","author":"Matsuura","year":"2009","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.semarthrit.2017.10.015_bib8","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1016\/j.jbspin.2010.12.003","article-title":"Obesity in primary antiphospholipid syndrome is associated with worse outcome","volume":"78","author":"Caldas","year":"2011","journal-title":"Joint Bone Spine"},{"key":"10.1016\/j.semarthrit.2017.10.015_bib9","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1177\/0961203307081847","article-title":"Impact of hypertension and hyperhomocysteinemia on arterial thrombosis in primary antiphospholipid syndrome","volume":"16","author":"de Souza","year":"2007","journal-title":"Lupus"},{"key":"10.1016\/j.semarthrit.2017.10.015_bib10","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1093\/rheumatology\/41.8.924","article-title":"A cross-sectional study of clinical thrombotic risk factors and preventive treatments in antiphospholipid syndrome","volume":"41","author":"Erkan","year":"2002","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.semarthrit.2017.10.015_bib11","first-page":"1560","article-title":"Antiphospholipid syndrome and asymptomatic carriers of antiphospholipid antibody: prospective analysis of 404 individuals","volume":"31","author":"Giron-Gonzalez","year":"2004","journal-title":"J Rheumatol"},{"key":"10.1016\/j.semarthrit.2017.10.015_bib12","doi-asserted-by":"crossref","first-page":"e3200","DOI":"10.1097\/MD.0000000000003200","article-title":"Impact of antiphospholipid syndrome and\/or systemic lupus erythematosus on the long-term adverse cardiovascular outcomes in patients after percutaneous coronary intervention: a systematic review and meta-analysis","volume":"95","author":"Bundhun","year":"2016","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.semarthrit.2017.10.015_bib13","doi-asserted-by":"crossref","first-page":"693","DOI":"10.3109\/07853890.2014.959559","article-title":"Markers of cardiovascular risk in patients with antiphospholipid syndrome: a meta-analysis of literature studies","volume":"46","author":"Ambrosino","year":"2014","journal-title":"Ann Med"},{"key":"10.1016\/j.semarthrit.2017.10.015_bib14","doi-asserted-by":"crossref","first-page":"2368","DOI":"10.1093\/eurheartj\/ehs380","article-title":"Reference intervals for common carotid intima-media thickness measured with echotracking: relation with risk factors","volume":"34","author":"Engelen","year":"2013","journal-title":"Eur Heart J"},{"key":"10.1016\/j.semarthrit.2017.10.015_bib15","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1177\/0961203315617841","article-title":"Primary antiphospholipid syndrome: absence of premature atherosclerosis in patients without traditional coronary artery disease risk factors","volume":"25","author":"Andrade","year":"2016","journal-title":"Lupus"},{"key":"10.1016\/j.semarthrit.2017.10.015_bib16","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.atherosclerosis.2011.06.044","article-title":"Carotid plaque, compared with carotid intima-media thickness, more accurately predicts coronary artery disease events: a meta-analysis","volume":"220","author":"Inaba","year":"2012","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.semarthrit.2017.10.015_bib17","doi-asserted-by":"crossref","first-page":"R54","DOI":"10.1186\/ar4489","article-title":"Atherosclerotic plaques occur in absence of intima-media thickening in both systemic sclerosis and systemic lupus erythematosus: a duplexsonography study of carotid and femoral arteries and follow-up for cardiovascular events","volume":"16","author":"Frerix","year":"2014","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.semarthrit.2017.10.015_bib18","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/j.semarthrit.2007.08.002","article-title":"Early atheroma in primary and secondary antiphospholipid syndrome: an intrinsic finding","volume":"37","author":"Belizna","year":"2008","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.semarthrit.2017.10.015_bib19","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1093\/rheumatology\/keh581","article-title":"Preclinical vascular disease in systemic lupus erythematosus and primary antiphospholipid syndrome","volume":"44","author":"Jimenez","year":"2005","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.semarthrit.2017.10.015_bib20","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1093\/rheumatology\/keg182","article-title":"Atherosclerosis in premenopausal women with antiphospholipid syndrome and systemic lupus erythematosus: a controlled study","volume":"42","author":"Vlachoyiannopoulos","year":"2003","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.semarthrit.2017.10.015_bib21","first-page":"299","article-title":"Subclinical atherosclerosis in primary antiphospholipid syndrome","volume":"15","author":"Caraba","year":"2010","journal-title":"Ann Romanian Soc Cell Biol"},{"key":"10.1016\/j.semarthrit.2017.10.015_bib22","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1177\/107602960200800205","article-title":"Are antiphospholipid antibodies an independent risk factor for atherosclerosis?","volume":"8","author":"Bilora","year":"2002","journal-title":"Clin Appl Thromb Hemost"},{"key":"10.1016\/j.semarthrit.2017.10.015_bib23","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1111\/j.1538-7836.2006.01753.x","article-title":"International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS)","volume":"4","author":"Miyakis","year":"2006","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.semarthrit.2017.10.015_bib24","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.1002\/art.1780400928","article-title":"Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus","volume":"40","author":"Hochberg","year":"1997","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.semarthrit.2017.10.015_bib25","doi-asserted-by":"crossref","first-page":"2889","DOI":"10.1016\/j.jacc.2013.11.002","article-title":"2013 ACC\/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology\/American Heart Association Task Force on Practice Guidelines","volume":"63","author":"Stone","year":"2014","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.semarthrit.2017.10.015_bib26","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1055\/s-0032-1304714","article-title":"Interference in antiphospholipid antibody assays","volume":"38","author":"Lakos","year":"2012","journal-title":"Semin Thromb Hemost"},{"key":"10.1016\/j.semarthrit.2017.10.015_bib27","doi-asserted-by":"crossref","first-page":"e0132307","DOI":"10.1371\/journal.pone.0132307","article-title":"The additive value of femoral ultrasound for subclinical atherosclerosis assessment in a single center cohort of 962 adults, including high risk patients with rheumatoid arthritis, human immunodeficiency virus infection and type 2 diabetes mellitus","volume":"10","author":"Protogerou","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.semarthrit.2017.10.015_bib28","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/j.autrev.2017.01.009","article-title":"Subclinical atherosclerosis in systemic lupus erythematosus: comparable risk with diabetes mellitus and rheumatoid arthritis","volume":"16","author":"Tektonidou","year":"2017","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.semarthrit.2017.10.015_bib29","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1007\/s12026-016-8887-6","article-title":"The role of MSCT angiography in early detection of lower limb arterial lesions in patients with antiphospholipid syndrome","volume":"65","author":"Saponjski","year":"2017","journal-title":"Immunol Res"},{"key":"10.1016\/j.semarthrit.2017.10.015_bib30","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1024\/0301-1526\/a000545","article-title":"Antiphospholipid antibodies and lower extremity peripheral arterial disease\u2014a systematic review and meta-analysis","volume":"45","author":"Gavier","year":"2016","journal-title":"Vasa"},{"key":"10.1016\/j.semarthrit.2017.10.015_bib31","doi-asserted-by":"crossref","first-page":"187","DOI":"10.5114\/reum.2016.62473","article-title":"Immunity and early atherosclerosis in the course of systemic lupus erythematosus, mixed connective tissue disease and antiphospholipid syndrome","volume":"54","author":"Haladyj","year":"2016","journal-title":"Reumatologia"},{"key":"10.1016\/j.semarthrit.2017.10.015_bib32","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1161\/ATVBAHA.113.302680","article-title":"Subclinical atherosclerosis in systemic lupus erythematosus and antiphospholipid syndrome: focus on \u03b22GPI-specific T cell response","volume":"34","author":"Conti","year":"2014","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.semarthrit.2017.10.015_bib33","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1177\/0003319708315304","article-title":"Flow-mediated arterial dilation in primary antiphospholipid syndrome","volume":"60","author":"Bilora","year":"2009","journal-title":"Angiology"},{"key":"10.1016\/j.semarthrit.2017.10.015_bib34","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1111\/j.1538-7836.2009.03308.x","article-title":"Atherosclerosis in thrombotic primary antiphospholipid syndrome","volume":"7","author":"Ames","year":"2009","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.semarthrit.2017.10.015_bib35","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1016\/j.thromres.2014.07.042","article-title":"Reduced plasma fibrin clot permeability and susceptibility to fibrinolysis are associated with increased intima-media thickness in patients with primary antiphospholipid syndrome","volume":"134","author":"Asztabski","year":"2014","journal-title":"Thromb Res"},{"key":"10.1016\/j.semarthrit.2017.10.015_bib36","doi-asserted-by":"crossref","first-page":"3210","DOI":"10.1002\/art.38785","article-title":"Role of Toll-like receptors 2 and 4 in mediating endothelial dysfunction and arterial remodeling in primary arterial antiphospholipid syndrome","volume":"66","author":"Benhamou","year":"2014","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.semarthrit.2017.10.015_bib37","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1001\/jama.2009.1346","article-title":"Vascular abnormalities, paraoxonase activity, and dysfunctional HDL in primary antiphospholipid syndrome","volume":"302","author":"Charakida","year":"2009","journal-title":"J Am Med Assoc"},{"key":"10.1016\/j.semarthrit.2017.10.015_bib38","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1177\/0961203307080224","article-title":"Impaired endothelial function and increased carotid intima-media thickness in association with elevated von Willebrand antigen level in primary antiphospholipid syndrome","volume":"16","author":"Der","year":"2007","journal-title":"Lupus"},{"key":"10.1016\/j.semarthrit.2017.10.015_bib39","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1007\/s00393-004-0601-8","article-title":"Oxidatively modified lipoproteins and their antibodies in patients with antiphospholipid syndrome and systemic lupus erythematosus","volume":"63","author":"Roch","year":"2004","journal-title":"Z Rheumatol"},{"key":"10.1016\/j.semarthrit.2017.10.015_bib40","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/j.autrev.2007.01.003","article-title":"Cardiac manifestations in antiphospholipid syndrome","volume":"6","author":"Soltesz","year":"2007","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.semarthrit.2017.10.015_bib41","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1136\/ard.62.7.607","article-title":"Increased carotid artery intima-media thickness may be associated with stroke in primary antiphospholipid syndrome","volume":"62","author":"Medina","year":"2003","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.semarthrit.2017.10.015_bib42","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1191\/0961203302lu165oa","article-title":"Anticardiolipin antibody titre and plasma homocysteine level independently predict intima media thickness of carotid arteries in subjects with idiopathic antiphospholipid antibodies","volume":"11","author":"Ames","year":"2002","journal-title":"Lupus"},{"key":"10.1016\/j.semarthrit.2017.10.015_bib43","doi-asserted-by":"crossref","first-page":"2227","DOI":"10.1161\/01.CIR.99.17.2227","article-title":"Immunolocalization of beta2-glycoprotein I (apolipoprotein H) to human atherosclerotic plaques: potential implications for lesion progression","volume":"99","author":"George","year":"1999","journal-title":"Circulation"},{"key":"10.1016\/j.semarthrit.2017.10.015_bib44","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1038\/nature10146","article-title":"Progress and challenges in translating the biology of atherosclerosis","volume":"473","author":"Libby","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.semarthrit.2017.10.015_bib45","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1191\/0961203306lu2267oa","article-title":"Oxidized low-density lipoprotein and beta2-glycoprotein I in patients with systemic lupus erythematosus and increased carotid intima-media thickness: implications in autoimmune-mediated atherosclerosis","volume":"15","author":"Lopez","year":"2006","journal-title":"Lupus"},{"key":"10.1016\/j.semarthrit.2017.10.015_bib46","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1007\/s00011-013-0652-x","article-title":"Antiphospholipid antibodies and sub-clinical atherosclerosis in the Coronary Artery Risk Development in Young Adults (CARDIA) cohort","volume":"62","author":"Majka","year":"2013","journal-title":"Inflamm Res"},{"key":"10.1016\/j.semarthrit.2017.10.015_bib47","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.5551\/jat.24372","article-title":"Involvement of TLR4 in oxidized LDL\/beta2GPI\/anti-beta2GPI-induced transformation of macrophages to foam cells","volume":"21","author":"Zhang","year":"2014","journal-title":"J Atheroscler Thromb"},{"key":"10.1016\/j.semarthrit.2017.10.015_bib48","doi-asserted-by":"crossref","first-page":"2096","DOI":"10.1093\/rheumatology\/kew054","article-title":"Oxidative stress in the pathogenesis of atherothrombosis associated with anti-phospholipid syndrome and systemic lupus erythematosus: new therapeutic approaches","volume":"55","author":"Lopez-Pedrera","year":"2016","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.semarthrit.2017.10.015_bib49","doi-asserted-by":"crossref","first-page":"5859","DOI":"10.1182\/blood-2011-12-400986","article-title":"Mitochondrial dysfunction in antiphospholipid syndrome: implications in the pathogenesis of the disease and effects of coenzyme Q(10) treatment","volume":"119","author":"Perez-Sanchez","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.semarthrit.2017.10.015_bib50","doi-asserted-by":"crossref","first-page":"2317","DOI":"10.1016\/j.jacc.2017.02.058","article-title":"Antiphospholipid syndrome: role of vascular endothelial cells and implications for risk stratification and targeted therapeutics","volume":"69","author":"Corban","year":"2017","journal-title":"J Am Coll Cardiol"}],"container-title":["Seminars in Arthritis and Rheumatism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049017217304936?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049017217304936?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,8,26]],"date-time":"2018-08-26T10:59:13Z","timestamp":1535281153000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0049017217304936"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,6]]},"references-count":50,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2018,6]]}},"alternative-id":["S0049017217304936"],"URL":"https:\/\/doi.org\/10.1016\/j.semarthrit.2017.10.015","relation":{},"ISSN":["0049-0172"],"issn-type":[{"value":"0049-0172","type":"print"}],"subject":[],"published":{"date-parts":[[2018,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Carotid and femoral atherosclerosis in antiphospholipid syndrome: Equivalent risk with diabetes mellitus in a case\u2013control study","name":"articletitle","label":"Article Title"},{"value":"Seminars in Arthritis and Rheumatism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.semarthrit.2017.10.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}